(Q39525356)

12 September 2017

1 reference

title

Resistance to cisplatin and analogues: mechanisms and potential clinical implications (English)

1 reference

12 September 2017

1 reference

A de Graeff

1

1 reference

12 September 2017

R J Slebos

series ordinal

2

1 reference

12 September 2017

S Rodenhuis

series ordinal

3

1 reference

12 September 2017

language of work or name

1 reference

1 January 1988

1 reference

Cancer Chemotherapy and Pharmacology

12 September 2017

published in

1 reference

12 September 2017

volume

22

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

325-332

1 reference

Detection of DNA cross-links in tumor cells with the ethidium bromide fluorescence assay

12 September 2017

cites work

1 reference

12 December 2020

Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug

1 reference

12 December 2020

Carrier-dependent and carrier-independent transport of anti-cancer alkylating agents

1 reference

12 December 2020

Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma

1 reference

12 December 2020

Experimental and clinical results with intraperitoneal cisplatin.

1 reference

12 December 2020

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues

1 reference

12 December 2020

Fundamental studies with cisplatin

1 reference

12 December 2020

Cisplatin: synthesis, antitumour activity and mechanism of action

1 reference

12 December 2020

Differential cytotoxicity and DNA cross-linking in normal and transformed human fibroblasts treated with cis-diamminedichloroplatinum(II)

1 reference

12 December 2020

Pharmacologic reversal of drug resistance in ovarian cancer.

1 reference

12 December 2020

Acute leukemia. A prototype of disseminated cancer

1 reference

12 December 2020

High-dose carboplatin in refractory ovarian cancer patients.

1 reference

12 December 2020

Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.

1 reference

12 December 2020

The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro

1 reference

12 December 2020

High-dose cisplatin in hypertonic saline in refractory ovarian cancer

1 reference

12 December 2020

cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II)

1 reference

12 December 2020

Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.

1 reference

12 December 2020

Drugs five years later. Cisplatin

1 reference

12 December 2020

Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches

1 reference

12 December 2020

Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diamminedichloroplatinum(II).

1 reference

12 December 2020

Whither carboplatin?--A replacement for or an alternative to cisplatin?

1 reference

12 December 2020

Interindividual human variation in cisplatinum sensitivity, predictable in an in vitro assay?

1 reference

12 December 2020

Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein.

1 reference

12 December 2020

Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).

1 reference

12 December 2020

Binding of an antitumor platinum compound to cells as influenced by physical factors and pharmacologically active agents

1 reference

12 December 2020

Drug resistance induction and cross-resistance studies with Pt-complexes.

1 reference

12 December 2020

Amino acid membrane transport properties of L1210 cells resistant to cisplatin.

1 reference

12 December 2020

Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum(II)

1 reference

12 December 2020

Multiple-drug resistance in human cancer

1 reference

12 December 2020

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

1 reference

12 December 2020

Clinical aspects of drug resistance.

1 reference

12 December 2020

In vivo and in vitro binding of platinum to metallothionein

1 reference

12 December 2020

Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).

1 reference

12 December 2020

Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells.

1 reference

12 December 2020

Rationale for development of platinum analogs

1 reference

12 December 2020

The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells.

1 reference

12 December 2020

DNA cross-linking and cytotoxicity induced by cis-diamminedichloroplatinum(II) in human normal and tumor cell lines

1 reference

12 December 2020

Development of a nucleotide precursor incorporation assay for testing drug sensitivity of human tumors

1 reference

12 December 2020

Walker rat carcinoma cells are exceptionally sensitive to cis-diamminedichloroplatinum(II) (cisplatin) and other difunctional agents but not defective in the removal of platinum-DNA adducts.

1 reference

12 December 2020

Binding of cis-dichlorodiammine platinum(II) to metallothionein in Ehrlich cells.

1 reference

12 December 2020

Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre-exposed in vitro to either X-irradiation or cisplatin.

1 reference

12 December 2020

An in vitro assay procedure to test chemotherapeutic drugs on cells from human solid tumors

1 reference

12 December 2020

cis-Diamminedichloroplatinum(II)-induced sister chromatid exchange: an indicator of sensitivity and heterogeneity in primary human tumor cell cultures

1 reference

12 December 2020

DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.

1 reference

12 December 2020

Glutathione metabolism as a determinant of therapeutic efficacy: a review

1 reference

12 December 2020

Alkylating agent resistance: in vitro studies with human cell lines

1 reference

12 December 2020

Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro

1 reference

12 December 2020

Possible mechanism for differences in sensitivity to cis-platinum in human prostate tumor cell lines.

1 reference

12 December 2020

Functions of metallothionein

1 reference

12 December 2020

Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II)

1 reference

12 December 2020

Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).

1 reference

12 December 2020

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

1 reference

12 December 2020

Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient.

1 reference

12 December 2020

In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin

1 reference

12 December 2020

Induction of metallothionein-I mRNA in cultured cells by heavy metals and iodoacetate: evidence for gratuitous inducers

1 reference

12 December 2020

Amplification of the metallothionein-I gene in cadmium-resistant mouse cells

1 reference

12 December 2020

Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy

1 reference

12 December 2020

The nature of inactivating lesions produced by platinum(II) complexes in phage lambda DNA.

1 reference

12 December 2020

Tumours from a cell strain with a high content of metallothionein show enhanced resistance against cis-dichlorodiammineplatinum.

1 reference

12 December 2020

A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells

1 reference

12 December 2020

Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs

1 reference

12 December 2020

DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity

1 reference

12 December 2020

Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells.

1 reference

12 December 2020

Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells

1 reference

12 December 2020

Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture.

1 reference

12 December 2020

Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

1 reference

12 December 2020

Drug resistance in cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00254240

1 reference

12 September 2017

1 reference